Does PEGFILGRASTIM Cause Hypovolaemia? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hypovolaemia have been filed in association with PEGFILGRASTIM (ZIEXTENZO). This represents 0.0% of all adverse event reports for PEGFILGRASTIM.
6
Reports of Hypovolaemia with PEGFILGRASTIM
0.0%
of all PEGFILGRASTIM reports
2
Deaths
5
Hospitalizations
How Dangerous Is Hypovolaemia From PEGFILGRASTIM?
Of the 6 reports, 2 (33.3%) resulted in death, 5 (83.3%) required hospitalization.
Is Hypovolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGFILGRASTIM. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does PEGFILGRASTIM Cause?
Device adhesion issue (11,326)
Wrong technique in product usage process (10,217)
Unintentional medical device removal (8,882)
Device malfunction (6,818)
Device use error (6,001)
Device issue (5,071)
Accidental exposure to product (4,967)
Device occlusion (3,239)
Off label use (3,228)
Bone pain (2,266)
What Other Drugs Cause Hypovolaemia?
FUROSEMIDE (346)
METFORMIN (281)
EMPAGLIFLOZIN (150)
SPIRONOLACTONE (123)
DEXAMETHASONE (117)
HYDROCHLOROTHIAZIDE (94)
PREDNISONE (91)
LISINOPRIL (86)
METOPROLOL (84)
ACETAMINOPHEN (77)
Which PEGFILGRASTIM Alternatives Have Lower Hypovolaemia Risk?
PEGFILGRASTIM vs PEGFILGRASTIM-APGF
PEGFILGRASTIM vs PEGFILGRASTIM-BMEZ
PEGFILGRASTIM vs PEGFILGRASTIM-CBQV
PEGFILGRASTIM vs PEGFILGRASTIM-JMDB
PEGFILGRASTIM vs PEGINTERFERON ALFA